24th Drug Design & Development Seminar (DDDS)

Scientific Board
Prof. Dr. Klaus Brehm
Julius-Maximilians University
Würzburg, Germany
Prof. Dr. Markus Engstler
Julius-Maximilians University
Würzburg, Germany
Prof. Dr. Paul M. Selzer
Boehringer Ingelheim Animal Health
Ingelheim am Rhein, Germany
Dr. Sandra Noack
Boehringer Ingelheim Animal Health
Ingelheim am Rhein, Germany
Organizer
German Society for Parasitology & Ludwig-Maximilians University Würzburg

About the Drug Design & Development Seminar (DDDS)
The Drug Design & Development Seminar (DDDS) was founded in 1999 as an active
working group of the German Society for Parasitology, by Prof. Dr. Peter Köhler (Univ.
of Zürich, CH), Prof. Dr. Rolf Walter (BNI, Hamburg, DE), and Prof. Dr. Heiner
Schirmer (Univ. of Heidelberg, DE). Since 2004 Prof. Dr. Paul M. Selzer (Boehringer
Ingelheim Animal Health, Ingelheim, DE) is the coordinator of the DDDS transferring
the meeting into an international well recognized scientific forum. Exchange of
scientific information about anti-parasitic chemotherapy between universities, industry,
and other research organizations continues to be important to accelerate antiparasitic
drug development. The DDDS is open to all scientists and professionals
interested in the field of anti-parasitic research. The DDDS aims at connecting human
and veterinary health by complementary approaches in medical and veterinary
parasitology and medicinal chemistry to aim and stimulate One-Health approaches to
combat parasitic diseases.

The main topics include but are not limited to:

• Target identification, characterization, and validation
• Identification of modulators
• Synthesis and optimization of lead compounds towards marketable drugs
• Testing active compounds in animal models